NOVATO, Calif.--(BUSINESS WIRE)--Aug. 1, 2006--Diamics, Inc., a San Francisco Bay-area, medical device and diagnostics company, today announced completion of its clinical trial for the company’s proprietary cervical collection device which is designed to improve screening for cervical cancer. Diamics will use the trial results, comprising more than 250 patients, as part of its 510k submission to the Food and Drug Administration.
